$4.84-0.10 (-2.02%)
Owlet, Inc.
Owlet, Inc. in the Healthcare sector is trading at $4.84. The stock is currently near its 52-week low of $3.86, remaining 49.1% below its 200-day moving average. Technical signals show neutral RSI of 38 and bullish MACD crossover, explaining why OWLT maintains its current current market pressure. The Whystock Score of 25/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, incl...
Owlet (OWLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KLA (KLAC) delivered earnings and revenue surprises of +2.60% and +0.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
SERV beat loss estimates and grew revenues in Q4, so why did operating losses widen sharply despite the stock jump?
Q4 2025 earnings and new 2026 guidance Owlet (OWLT) is back in focus after reporting its fourth quarter and full year 2025 results alongside fresh 2026 revenue guidance, giving you a clearer picture of both recent performance and management expectations. For Q4 2025, Owlet reported sales of US$26.6 million compared with US$20.5 million a year earlier. The company recorded a net loss of US$9.2 million, similar to the US$9.1 million loss in the prior year period. Basic and diluted loss per...
Owlet, Inc. has reported its fourth-quarter and full-year 2025 results, with Q4 sales of US$26.6 million versus US$20.5 million a year earlier and a quarterly net loss of US$9.2 million, alongside issuing 2026 revenue guidance of US$126 million to US$130 million and outlining new product launches and regulatory clearances. While the company’s full-year 2025 net loss widened to US$39.7 million even as sales increased to US$105.7 million, management is highlighting growth in its Owlet 360...